Connected Smart Drug Delivery Systems Market
完整報告名稱與涵蓋範圍
Connected Smart Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product, By Therapeutic Area (Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Others), By End-User, By Region, And Segment Forecasts, 2025-2034
報告摘要
The Connected Smart Drug Delivery Systems Market on a global scale was estimated at USD 4.2 Billion in 2024 and is expected to attain USD 10.5 Billion by 2034, with a projected CAGR of 10.0% between 2025 and 2034.
The Connected Smart Drug Delivery Systems sector involves the devices which perform multiple functions with the highest degree of smartness. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Connected Smart Drug Delivery Systems Market Snapshot
Chapter 4. Global Connected Smart Drug Delivery Systems Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. COVID 19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Connected Inhalers
5.2.2. Connected Autoinjectors
5.2.3. Connected Needle-Free Injectors
5.2.4. Connected Pen injectors
5.2.5. Connected Insulin Pumps
5.2.6. Connected Wearable Injectors/Patch Pumps
5.2.7. Add-On Sensors
Chapter 6. Connected Smart Drug Delivery Systems Market Segmentation 2: By Applications Estimates & Trend Analysis
6.1. By Therapeutic Area Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
6.2.1. Metabolic Disorders
6.2.2. Neurological Disorders
6.2.3. Respiratory Disorders
6.2.4. Others
Chapter 7. Connected Smart Drug Delivery Systems Market Segmentation 3: By End-Users Estimates & Trend Analysis
7.1. By Therapeutic Area Analysis & Market Share, 2024 & 2034
7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
7.2.1. Hospital
7.2.2. Clinics
7.2.3. Homecare
Chapter 8. Connected Smart Drug Delivery Systems Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Products, 2021-2034
8.1.2. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Therapeutic Area, 2021-2034
8.1.3. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by End-Users, 2021-2034
8.1.4. North America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) Estimates and Forecasts by Country, 2021-2034
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2021-2034
8.2.2. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2021-2034
8.2.3. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2021-2034
8.2.4. Europe Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2021-2034
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, 2021-2034
8.3.2. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, 2021-2034
8.3.3. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, 2021-2034
8.3.4. Asia Pacific Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, 2021-2034
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2021-2034
8.4.2. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2021-2034
8.4.3. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.4.4. Latin America Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) by Country, (US$ Million) 2021-2034
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. MEA
8.5.1. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Products, (US$ Million) 2021-2034
8.5.2. MEA Connected Smart Drug Delivery Systems Market Revenue (US$ Million) and Volume (No. of Units) By Therapeutic Area, (US$ Million) 2021-2034
8.5.3. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
8.5.4. MEA Connected Smart Drug Delivery Systems Market revenue (US$ Million) and volume (No. of Units) by Country, (US$ Million) 2021-2034
8.5.4.1. South Africa
8.5.4.2. GCC Countries
8.5.4.3. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. BIOCORP
9.2.2. Elcam Drug Delivery Devices (E3D)
9.2.3. Novo Nordisk
9.2.4. Merck
9.2.5. Pneuma Respiratory
9.2.6. H&T Presspart
9.2.7. Nemera
9.2.8. Ypsomed Holdings
9.2.9. Unolife Corporation
9.2.10. Quio Technologies
9.2.11. SHL Group
9.2.12. Haselmeier Inc.
9.2.13. Portal Instruments Inc
9.2.14. West Pharmaceutical Services Inc.
9.2.15. Emperra GmbH E-Health Technologies
9.2.16. Amiko Digital Health Limited
9.2.17. Cognita Labs
9.2.18. DIAMESCO CO., Ltd.｜
9.2.19. Eitan Medical (Q Core Medical Ltd., Avoset Health, Sorrel Medical)
9.2.20. Enable Injections
9.2.21. Bigfoot Biomedical Inc.
9.2.22. Medtronic Plc
9.2.23. Companion Medical
9.2.25. Cohero Health, Inc.
9.2.26. Propeller Health
9.2.27. Pendiq Intelligent Diabetes Care
9.2.28. Phillips-Medisize
9.2.29. Becton, Dickinson and Company (BD)
9.2.30. Noble International Inc
9.2.31. etectRx
9.2.32. Aterica Inc.
9.2.33. Findair Sp. z o. o.
9.2.34. Recipharm AB
9.2.35. Aero Pump GmbH
9.2.36. Jiangsu Delfu medical device Co.,Ltd
8.3. List of Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們